Scarica l'app Stockscreener
38.46
3.22%
1.20
Pre-mercato:
38.11
-0.35
-0.91%
Agios Pharmaceuticals Inc Azioni (AGIO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
42.73%
12.46
|
8.726 | 10.73 | 8.964 | 8.615 |
| Cost Of Revenue |
56.87%
1.702
|
1.085 | 1.26 | 0.783 | 1.495 |
| Gross Profit |
40.73%
10.75
|
7.641 | 9.47 | 8.181 | 7.12 |
Operating Expenses
|
20.60%
137.81
|
114.27 | 134.51 | 110.99 | 112.94 |
| Benefits Costs and Expenses |
20.94%
139.51
|
115.36 | 116.13 | -992.07 | 114.43 |
| Costs And Expenses |
20.94%
139.51
|
115.36 | 135.77 | 111.78 | 114.43 |
| Operating Income/Loss |
19.16%
-127.06
|
-106.63 | -125.04 | -102.81 | -105.82 |
| Income/Loss From Continuing Operations Before Tax |
42.30%
-127.06
|
-89.29 | -105.40 | 1,001.03 | -96.12 |
| Income/Loss From Continuing Operations After Tax |
25.46%
-112.02
|
-89.29 | -96.52 | 947.91 | -96.12 |
|
Net Income/Loss
|
25.46%
-112.02
|
-89.29 | -96.52 | 947.91 | -96.12 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.82%
57.93
|
57.46 | 0.0981 | 56.94 | 56.80 |
| Diluted Average Shares |
0.82%
57.93
|
57.46 | 0.3079 | 58.43 | 56.80 |
| Basic Earnings Per Share |
24.52%
-1.93
|
-1.55 | -1.72 | 16.65 | -1.69 |
| Diluted Earnings Per Share |
24.52%
-1.93
|
-1.55 | -1.74 | 16.22 | -1.69 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):